NDC 64764-918

ULORIC

Febuxostat

ULORIC is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Febuxostat.

Product ID64764-918_24d10877-2fcd-4556-8721-ff48edeb93de
NDC64764-918
Product TypeHuman Prescription Drug
Proprietary NameULORIC
Generic NameFebuxostat
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2009-02-13
Marketing CategoryNDA / NDA
Application NumberNDA021856
Labeler NameTakeda Pharmaceuticals America, Inc.
Substance NameFEBUXOSTAT
Active Ingredient Strength40 mg/1
Pharm ClassesXanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 64764-918-11

10 BLISTER PACK in 1 CARTON (64764-918-11) > 10 TABLET in 1 BLISTER PACK
Marketing Start Date2009-02-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64764-918-01 [64764091801]

ULORIC TABLET
Marketing CategoryNDA
Application NumberNDA021856
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-02-23
Marketing End Date2011-03-09

NDC 64764-918-18 [64764091818]

ULORIC TABLET
Marketing CategoryNDA
Application NumberNDA021856
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-02-13

NDC 64764-918-30 [64764091830]

ULORIC TABLET
Marketing CategoryNDA
Application NumberNDA021856
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-02-13

NDC 64764-918-90 [64764091890]

ULORIC TABLET
Marketing CategoryNDA
Application NumberNDA021856
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-02-13

NDC 64764-918-11 [64764091811]

ULORIC TABLET
Marketing CategoryNDA
Application NumberNDA021856
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-02-13

Drug Details

Pharmacological Class

  • Xanthine Oxidase Inhibitor [EPC]
  • Xanthine Oxidase Inhibitors [MoA]

Medicade Reported Pricing

64764091830 ULORIC 40 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "ULORIC" or generic name "Febuxostat"

NDCBrand NameGeneric Name
21695-516ULORICfebuxostat
43353-305ULORICfebuxostat
55154-5158ULORICfebuxostat
55154-5159ULORICfebuxostat
64764-677ULORICULORIC
64764-918ULORICULORIC
0054-0413FebuxostatFebuxostat
0054-0414FebuxostatFebuxostat
0378-3925Febuxostatfebuxostat
0378-3926Febuxostatfebuxostat
0527-2244FEBUXOSTATfebuxostat
0527-2248FEBUXOSTATfebuxostat
14445-156FebuxostatFebuxostat
14445-157FebuxostatFebuxostat
16714-059FebuxostatFebuxostat
16714-060FebuxostatFebuxostat
27808-206Febuxostatfebuxostat
27808-207Febuxostatfebuxostat
43547-295FEBUXOSTATfebuxostat
43547-296FEBUXOSTATfebuxostat
46708-190Febuxostatfebuxostat
46708-191Febuxostatfebuxostat
47335-721FebuxostatFebuxostat
47335-722FebuxostatFebuxostat
48792-7905FEBUXOSTATfebuxostat
48792-7906FEBUXOSTATfebuxostat
51407-293FebuxostatFebuxostat
51407-294FebuxostatFebuxostat
55111-796FebuxostatFebuxostat
55111-797FebuxostatFebuxostat
60687-538FebuxostatFebuxostat
62332-190Febuxostatfebuxostat
62332-191Febuxostatfebuxostat
63304-864FebuxostatFebuxostat

Trademark Results [ULORIC]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ULORIC
ULORIC
85060525 3916684 Live/Registered
TEIJIN KABUSHIKI KAISHA (TEIJIN LIMITED)
2010-06-11
ULORIC
ULORIC
78108573 2739132 Live/Registered
TEIJIN KABUSHIKI KAISHA (TEIJIN LIMITED)
2002-02-13
ULORIC
ULORIC
77671366 not registered Dead/Abandoned
Takeda Pharmaceuticals North America, Inc.
2009-02-16
ULORIC
ULORIC
77671352 3800552 Live/Registered
TEIJIN KABUSHIKI KAISHA (TEIJIN LIMITED)
2009-02-16
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.